Accepted Manuscript High expression of survivin and its splice variants survivin ΔEx3 and survivin 2B in oral cancers Rupa Mishra, Vinayak Palve, Sadhana Kannan, Sagar Pawar, Tanuja Teni PII:
S2212-4403(15)01066-4
DOI:
10.1016/j.oooo.2015.06.027
Reference:
OOOO 1230
To appear in:
Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology
Received Date: 1 March 2015 Revised Date:
3 June 2015
Accepted Date: 8 June 2015
Please cite this article as: Mishra R, Palve V, Kannan S, Pawar S, Teni T, High expression of survivin and its splice variants survivin ΔEx3 and survivin 2B in oral cancers, Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology (2015), doi: 10.1016/j.oooo.2015.06.027. This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.
ACCEPTED MANUSCRIPT
Title: High expression of survivin and its splice variants survivin ∆Ex3 and survivin 2B in oral cancers
a
RI PT
Rupa Mishraa, Vinayak Palveb, Sadhana Kannanc, Sagar Pawara, Tanuja Tenia * Teni Lab, Advanced Centre for Treatment, Research and Education in Cancer
(ACTREC), Tata Memorial Centre, Kharghar, Navi Mumbai-410210, India
Genomics Applications and Information Technology (GANIT) Labs, Institute of
SC
b
c
M AN U
Bioinformatics and Applied Biotechnology (IBAB), Bangalore 560100, India Epidemiology and Clinical Trial Unit (ECTU), Advanced Centre for Treatment,
Research and Education in Cancer (ACTREC), Tata Memorial Centre, Kharghar, Navi Mumbai-410210, India
Dr. Tanuja R Teni
TE D
Corresponding Author
Advanced Centre for Treatment, Research and Education in Cancer
EP
Tata Memorial Centre,
India.
AC C
Kharghar, Navi Mumbai 410210
Tel: 91-22-27405071
Fax: 91-22-27405085
Email:
[email protected]
Conflict of Interest: None
ACCEPTED MANUSCRIPT
Complete Manuscript word count: 6,272 Number of references: 68
RI PT
Number of Figures: 5 Number of tables: 4
SC
Funding: The work was supported by funds from Lady Tata Memorial Trust (LTMT), Mumbai. The sponsors did not have any role in study design, data collection and
AC C
EP
TE D
M AN U
analysis or in the decision to write and submit the article for publication.
ACCEPTED MANUSCRIPT
Abstract: Objectives: We have previously reported inactivation of p53 in 54% of Indian oral cancer
RI PT
patients. Survivin, a p53 target gene and an Inhibitor of Apoptosis Protein (IAP) is overexpressed in several cancers, including oral cancers. Studies assessing the role of survivin and its splice variants in oral cancers are however rare.
SC
Materials and Methods: The expression of six survivin isoforms in 4 oral cancer cell lines (AW8507, AW13516, UPCI-SCC040, UPCI-SCC029B), a dysplastic oral cell line
M AN U
(DOK), 75 paired oral tumor and adjacent normal tissues and 12 normal oral tissues from healthy individuals was analyzed by real time PCR. The expression was correlated with clinicopathological parameters, which included age, sex, TNM staging, tobacco and/or alcohol consumption, site and differentiation status of tumor.
TE D
Results: This is the first study to demonstrate overexpression of the six characterized survivin isoforms in oral cancers as compared to normals (p